Longitudinal study of immunity to SARS-CoV2 in ocrelizumab-treated MS patients up to 2 years after COVID-19 vaccination.

Ann Clin Transl Neurol · 2024 · PMC11251481 · PMID 38713096

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

Discussion Primary mRNA COVID‐19 vaccination series induced a highly significant increase in anti‐Spike binding and Wuhan neutralizing antibody levels in both infected and uninfected VIOLA participants (Fig. 3A1,B1 ).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.